de_DE
en_GBThe Fluxergy Analyzer System, which utilizes state-of-the-art Sample-to-Answer-RT-PCR and microfluidics technology, has been shown to identify bacteria and viruses in one hour. By designing your own lab-developed tests you can eliminate the need to send samples out to central laboratories. You will save money on shipping, save time, and improve your in-house testing capabilities at an affordable price point.
FAST PCR: DETECT DNA OR RNA
IN ONE HOUR
HOW TO RUN A FLUXERGY PCR
Place Prepared Sample into Fluxergy Card
Insert Fluxergy Card into Fluxergy Analyzer
Get PCR Results in One Hour
PCR TESTS: SIMPLE SAMPLE PREPARATION
WITH NO EXTRACTION REQUIRED
Viral Transport Media
Vortexer (Not Included)
Fluxergy Reaction Mix
Mini Centifuge
Fluxergy Card
Fluxergy Analyzer
Fluxergy Works (Computer not included)
DNA extraction is NOT required. The Fluxergy System utilizes state-of-the-artSample-to-Answer-RT-PCRandmicrofluidics technology for a simplified workflow.*
*Refer to Instructions for Use for complete user instructions for the Fluxergy Test Kit COVID-19. This device is solely intended to be used by healthcare professionals. Rev. 3-24-21
SPECIFICATIONS: FLUXERGY TEST KIT
STREP EQUI EQUI
| Assay Specifications | |
|---|---|
| Test Type | RT-PCR, Direct |
| Time to Result | ~35 minutes |
| Sample Preparation | 8-24 hours for enrichment, ~3 min from reagent thaw* |
| Sample Type | Environmental Swab |
| Compatible Enrichments | Selenite F Broth |
| Required Sample Volume | 14µL of post-enriched Selenite-F Broth sample.* |
| Gene Targets | Salmonella Spp. InvA |
| Platform Specifications | |
|---|---|
| Analyzer Size | 26.19 cm x 13.13 cm x 25.80 cm |
| Analyzer Weight | 6.8 kg |
| Power Input | 12V DC, 7A |
| Operating Temperature | 15°C – 30°C |
| Storage Temperature | 15°C – 30°C |
| Operating Humidity | 10%-85% |
| Recommended Computer Requirements | Operating System: OS must be 64-bit, Windows 10 v1151 Processor: Intel Core i5 2.5GHz or equivalent Ram: 8GB DDR4 HDD: 250GB Screen: 1080p USB: 2x2.0 port (for scanner and mouse) Networking: Ethernet port |
| Data Analysis Tools | Qualitative Result Interpretation |
*Fluxergy does not sell diagnostic test kits for animals and no Fluxergy products have been cleared or approved by the USDA for any use. Fluxergy’s current veterinary product offerings are limited to individual laboratory components for use by experienced professional users in developing their own laboratory tests for research or animal use. V. 4-09-21
COMING SOON: FLUXERGY TEST KIT
EQUINE INFLAMMATION PANEL
A Best-in-Class Inflammation Test at the Point-of-Care
The Fluxergy Equine Inflammation Panel LFA, which utilizes lateral flow technology, will provide semi-quantitative results for three acute phase proteins / inflammation biomarkers.
R&D Snapshot – Assays that measure foal and adult IgG levels measures on the same Analyzer that conducts PCR:
*Fluxergy does not sell diagnostic test kits for animals and no Fluxergy products have been cleared or approved by the USDA for any use. Fluxergy’s current veterinary product offerings are limited to individual laboratory components for use by experienced professional users in developing their own laboratory tests for research or animal use. V. 4-09-21
COMMITTED TO COMPLIANCE:
CE-IVD, ISO 13485:2016, AND MDSAP
Fluxergy has obtained CE marking for its one-hour COVID-19RT-PCR test, to use by healthcare professionals as an in vitro diagnostics (IVD) for the detection of SARS-CoV-2. The CE-mark will allow Fluxergy’s innovative testing platform to enter the European Union market and any other markets that accept CE-marking as valid regulatory approval.
In December 2020, Fluxergy received dual ISO-1 3485:201 6 and MDSAP certifications. ISO 1 3485:201 6 is the medical device industry’s most widely used international standard for quality management systems to design, develop, produce, and deliver products. MDSAP certification satisfies the quality system requirements of the regulatory authorities participating in the program, including the U.S. Food and Drug Administration (FDA), Health Canada, Brazil’s Agência Nacional de Vigilância Sanitária and Australia’s Therapeutic Goods Administration.
“Fluxergy is dedicated to producing tools that make health information accessible and available to everyone. We are focused on bringing our unique diagnostic products to market rapidly and innovatively, ensuring our end-users always have a product with the latest technology while maintaining the highest level of quality.
We do this through a data-driven process that focuses on continuous improvement.
Fluxergy is seeking commercial partnerships with healthcare providers and potential international go-to-market partners in Europe, Asia, and Australia”
– Dr. Ali Tinazli, Chief Commerical Officer